ArticleHistology and histopathology2022
AADAC promotes therapeutic activity of cisplatin and imatinib against ovarian cancer cells.
Haijing Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it